HANGZHOU, China, Aug. 23, 2010 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCBB:CCEL) ("the Company"), one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences (SEB), the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development (R&D) facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services. The new SEB facility occupies over 25,000 square feet and includes four Good Manufacturing Practice (cGMP) laboratories and administrative offices.
